Azithromycin vs doxycycline
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
1,835 questions · 1,886 findings · 74 reviews · Skin
No studies found 542 · 28.7%GRADE not reported 130 · 6.9%Very low 326 · 17.3%Low 434 · 23%Moderate 348 · 18.5%High 106 · 5.6%
Azithromycin vs doxycycline
Participant‐assessed improvement in rosacea severity · Participants with rosacea
It is very uncertain whether azithromycin changes participant‐assessed improvement in rosacea severity compared with doxycycline 100 mg (very low certainty).
1 finding from 1 review
- RR 0.98 [0.77, 1.25]1 study · 67 participantsVery low
Azithromycin vs doxycycline
Proportion of participants with adverse event · Participants with rosacea
It is very uncertain whether azithromycin changes proportion of participants with adverse event compared with doxycycline 100 mg (very low certainty).
1 finding from 1 review
- RR 1.62 [0.32, 8.26]1 study · 67 participantsVery low
Azithromycin vs doxycycline
Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Azithromycin vs doxycycline
Assessment of erythema or telangiectasia ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Azithromycin vs doxycycline
Lesion count · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 67 participantsVery low
Azithromycin vs doxycycline
Time needed until improvement of the skin lesions · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Azithromycin vs doxycycline
Duration of remission · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 67 participantsVery low
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Azelaic acid vs placebo
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Proportion of participants with adverse event · Participants with rosacea
Doxycycline 40 mg + metronidazole 1% gel may leads to lower proportion of participants with adverse event compared with doxycycline 100 mg + metronidazole 1% gel (low certainty).
1 finding from 1 review
- RR 0.25 [0.11, 0.54]1 study · 91 participantsLow
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Physician‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 91 participantsLow
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Assessment of erythema or telangiectasia · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 91 participantsLow
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Lesion count · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 91 participantsLow
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Time needed until improvement of the skin lesions · Participants with rosacea
1 finding from 1 review
- no estimate extracted1 study · 91 participantsLow
Doxycycline 40 mg + metronidazole 1% gel vs doxycycline 100 mg + metronidazole 1% gel
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel
Participant‐assessed improvement in rosacea severity · Participants with rosacea
Doxycycline 40 mg + azelaic acid gel showed no clear difference in participant‐assessed improvement in rosacea severity Excellent… compared with doxycycline 40 mg + metronidazole gel (high certainty).
1 finding from 1 review
- RR 1.05 [0.79, 1.4]1 study · 207 participantsHigh
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel
Proportion of participants with adverse event · Participants with rosacea
Doxycycline 40 mg + azelaic acid gel showed no clear difference in proportion of participants with adverse event compared with doxycycline 40 mg + metronidazole gel (high certainty).
1 finding from 1 review
- RR 0.27 [0.06, 1.28]1 study · 207 participantsHigh